Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06162403 · ClinicalTrials.gov registry record · NA
Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study
A NA study of Chemotherapy-induced Peripheral Neuropathy and Peripheral Nerve Stimulation, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06162403 is a NA study of Chemotherapy-induced Peripheral Neuropathy and Peripheral Nerve Stimulation that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 10 participants, below the 138-participant average among 29 other Chemotherapy-induced Peripheral Neuropathy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06162403, a NA study of Chemotherapy-induced Peripheral Neuropathy and Peripheral Nerve Stimulation, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if peripheral nerve stimulation (PNS) can help to improve pain in participants with CIPN.
Conditions Studied
Interventions
- OTHER Peripheral Nerve Stimulation
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-02-22 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06162403
The ClinicalTrials.gov registry entry for NCT06162403 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 138-participant average among 29 other Chemotherapy-induced Peripheral Neuropathy trials with a reported enrollment target (93% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chemotherapy-induced Peripheral Neuropathy appearing as the primary indexed condition, and to 1 intervention - of which Peripheral Nerve Stimulation is the first listed.
NCT06162403 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06162403 about?
NCT06162403 is a clinical study titled "Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study". To learn if peripheral nerve stimulation (PNS) can help to improve pain in participants with CIPN.
What is the current status of trial NCT06162403?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-02-22. Estimated completion is 2027-12-31.
What conditions does trial NCT06162403 study?
This clinical trial studies the following conditions: Chemotherapy-induced Peripheral Neuropathy, Peripheral Nerve Stimulation.
What interventions are being tested in trial NCT06162403?
The interventions under investigation include: Peripheral Nerve Stimulation (OTHER).
Who is sponsoring clinical trial NCT06162403?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06162403 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chemotherapy-induced Peripheral Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cryocompression for CIPN
RECRUITING · NA
-
VGAIT for Chemotherapy-induced Peripheral Neuropathy
RECRUITING · NA
-
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
RECRUITING · NA
-
Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy
RECRUITING · NA
-
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
RECRUITING · NA
-
Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2
RECRUITING · NA
Explore more on PlainTrial
Chemotherapy-induced Peripheral Neuropathy
All registered trials for this condition
Peripheral Nerve Stimulation
All registered trials for this condition
Texas
All trials with a study site in Texas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.